Assessing physical symptoms during the perinatal period: Reliability and validity of the Primary Health Questionnaire Somatic Symptom Subscale (PHQ-15) by Wilkie, Stephanie et al.
  
 
Assessing physical symptoms during the postpartum period: Reliability and validity 
of the Primary Health Questionnaire Somatic Symptom Subscale (PHQ-15) 
 
Stephanie Wilkie1, Rosalind Crawley2, Susan Button3, Alexandra Thornton4 and 
Susan Ayers4 
 
1 Department of Psychology, David Goldman Informatics Centre, St. Peter’s Campus, 
University of Sunderland, Sunderland, SR6 0DD, U.K. stephanie.wilkie@sunderland.ac.uk 
Tel: 0044 (0)191 515 2601 (corresponding author) 
2 Department of Psychology, David Goldman Informatics Centre, St. Peter’s Campus, 
University of Sunderland, Sunderland, SR6 0DD, U.K. roz.crawley@sunderland.ac.uk Tel: 
0044 (0)191 515 2522 
3 Department of Adult Nursing and Paramedic Science, University of Greenwich, Avery 
Hill Road, London SE9 2UG. Susan.Button@gre.ac.uk. 0044 (0)20 8331 8197 
4 Centre for Maternal and Child Health Research, School of Health Sciences, 
City University London, Northampton Square, London, EC1V 0HB Susan.Ayers@city.ac.uk 
Tel: 0044 (0)207 040 5834 
Alex.Thornton@city.ac.uk Tel: 0044 (0)207 5427 
 
 
Keywords: Postpartum, pregnancy, symptoms, physical health, PHQ-15, reliability, validity 
 
 
 
  
 
 
Abstract  
Introduction: This study aimed to establish the reliability and validity of the Primary 
Health Questionnaire Somatic Symptom Severity Subscale (PHQ-15) for postpartum 
women. 
Methods: Women (N = 495) completed the PHQ-15 approximately six weeks 
postpartum during the baseline phase of a randomised controlled trial evaluating a 
writing intervention for postnatal health in England. Reliability was assessed using 
internal consistency statistics and convergent validity by comparing differences in 
self-reported physical health, health-related quality of life (QoL), and primary care 
usage by PHQ-15 symptom severity category. 
Results:  Cronbach’s α for the PHQ-15 was 0.73 and item-total statistics met 
recommended guidelines. Validity analyses showed 6% of women reported severe 
symptoms, 17% medium, 50% low, and 27% minimal symptoms. Women with severe 
symptoms reported poorer overall physical health, poorer physical health-related 
QoL, and greater use of primary care. Women with severe symptoms also rated their 
baby’s health as worse and used primary care more for their baby. 
Discussion:  This study suggests the PHQ-15 has the potential to be a useful and valid 
measure of physical symptoms in postpartum women in high-income countries.  
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 Introduction 
Pregnancy, birth and the postpartum period involve huge physiological changes and 
women often experience normal and abnormal physical symptoms during this time 
(Ansara et al, 2005; Brown, 1998; Woolhouse et al, 2014; Kelley, Russo & Caton, 
2001) with over 90% of women reporting physical health problems after birth 
(Brown, 1998, Cooklin et al, 2013). There is substantial evidence from other 
populations that physical symptoms are associated with psychological symptoms 
[Henningsen et al 2003]. Less research has been done with women during pregnancy 
and postpartum but the findings are consistent with the broader literature, showing 
physical symptoms can be associated with psychological problems such as 
depression, anxiety or somatic disorders (Woolhouse et al, 2014; Kelley, Russo & 
Caton, 2001). For example, a longitudinal study of women in pregnancy found that 
physical symptoms in the second trimester of pregnancy predicted symptoms of 
depression in the last trimester (Kamysheeva et al 2010). A population study of 
78,660 women in Norway found that women with a previous and recent history of 
sexual violence were approximately seven times more likely to suffer from eight or 
more physical symptoms in pregnancy (Lukasse et al 2012).  High levels of physical 
symptoms during pregnancy and after birth are therefore associated with poor 
emotional and physical wellbeing in women. They may also affect their baby. 
Women’s wellbeing during pregnancy can affect the developing foetus. Severe 
symptoms associated with health anxiety or somatic disorders may also heighten 
women’s concerns about their own and/or their baby’s health.  It is therefore 
important to examine physical symptoms in pregnancy and after birth for a number of 
reasons, such as discerning normal from abnormal physical symptoms; identifying 
 women with a high number of physical symptoms who may be at greater risk of 
psychological problems; or as a potential marker of sexual abuse.  
The current study focused on measuring the physical symptoms during the 
postpartum period and how they are measured is important.  Various measures of 
physical symptoms are available but few are validated for use in postpartum samples. 
One measure of physical symptoms is the Primary Health Questionnaire Somatic 
Symptom Subscale (PHQ-15) (Kroeke, Spitzer & Williams, 2002).  The PHQ-15 was 
originally designed to assess “15 somatic symptoms or symptom clusters most 
prevalent in somatization disorder” and was initially validated in both primary care 
and obstetric-gynecology clinical settings (p. 259) (Kroeke, Spitzer, Williams 2002).  
Initial results indicated symptom severity as measured by the PHQ-15 was linked to 
lower functional health and increased healthcare usage and disability days.  The PHQ-
15 has a number of advantages in that it is widely used (Interian et al, 2006; Korber et 
al, 2011; van Ravesteijn et al, 2009), is considered reliable and valid for general 
(Kocalevent, Hinz & Brahler, 2013; Nordin, Palmquist & Nordin, 2013) and clinical 
populations (Gierk et al, 2015; Han et al, 2009; Hyphantis et al, 2014; Interian et al, 
2006), has been translated into several languages (Han et al, 2009; Hyphantis et al, 
2014; Kocalevent, Hinz & Brahler, 2013; Korber et al, 2011; Nordin, Palmquist & 
Nordin, 2013; van Ravesteijn et al, 2009), and has been widely implemented in 
healthcare.  It also includes items that assess the severity of the most common 
symptoms in postpartum women including tiredness and musculoskeletal problems 
(Woolhouse et al, 2014; Cooklin et al 2013), as well as symptoms associated with 
poor self-rated health such as headache, stomach pain, nausea and musculoskeletal 
problems (Schytt et al 2005).    
 In the original PHQ-15 validation study, the obstetric-gynecology sample was 
not disaggregated so evidence of its reliability and validity for postpartum women 
specifically was not established.  Whilst subsequent studies have confirmed the PHQ-
15’s suitability in other clinical populations (Han et al, 2009; Hyphantis et al, 2014; 
Interian et al, 2006), evidence of the reliability and convergent validity of the PHQ-15 
for use with postpartum women still needs to be confirmed as “symptoms can result 
from normal physiological changes in pregnancy and the early post-partum period, so 
therefore need to be assessed with care” (Howard et al, 2014; p. 384). To our 
knowledge, only one prior study used the PHQ-15 with a perinatal sample and this 
was in a low-income country “where the burden of under-nutrition and infectious 
disease morbidity is high” (Senturk et al, 2006; p. 340)  In this study, a modified 
version of the PHQ-15 was implemented that: 1) eliminated two items regarding 
feeling tired/having low energy and problems sleeping based on an overlap with 
another study measure, and 2) modified item wording regarding menstruation to 
vaginal discharge.  This study found the PHQ-15 predicted poorer daily functioning 
(Senturk et al, 2006), providing initial evidence of suitability for use with perinatal 
women. However, the generalizability of these findings are limited to women in low-
income countries when using a modified version of the PHQ-15.  
The aim of the present study was therefore to examine whether evidence for 
the reliability and convergent validity of the standard PHQ-15 exists for postpartum 
sample from a high-income country.  Evidence of reliability was explored using 
internal consistency statistics chosen to facilitate comparison with values reported in 
prior studies.   Evidence of convergent validity was established by examining 
differences between women with minimal, low, medium and high levels of physical 
symptoms in self-rated physical health, physical and mental health related quality of 
 life (QoL), and primary care usage. In addition, differences in women’s ratings of 
their babies’ physical health and primary care usage were examined.  The following 
hypotheses were tested: 
HY1:  The internal consistency statistics for the PHQ-15 in this postpartum 
sample from a high-income country will be similar to values reported in other 
populations. 
HY2:  Compared with women in other severity groups, women high in PHQ-
15 symptom severity will:  
HY2A:  rate their physical health lower,  
HY2B:  report lower health-related quality of life, and  
HY2C:  report greater primary care use.  
HY3:  Compared with women in other severity groups, women high in PHQ-
15 symptom severity will: 
HY3A:  rate their baby’s physical health lower and  
HY3B:  report greater primary care use for the baby.    
 
Methods 
Design 
This study examines evidence for the reliability and convergent validity of the PHQ-
15 with postpartum women based on a secondary analysis of data collected as part of 
a randomised controlled trial evaluating a writing intervention for improving 
women’s postnatal health [REF removed for blind review].  Data presented here are 
from the baseline measures completed prior to intervention, at approximately six to 
eight weeks postpartum.  
 
 Procedure 
The project was approved by an NHS Research Ethics Committee. Participants were 
recruited from 11 acute NHS hospital trusts in England between October 2013 and 
December 2014.  All were aged 18 years or older and had given birth to a live infant 
after 26 weeks gestation. All eligible women (N = 7986) in the 11 NHS Trusts were 
sent a letter inviting them to take part approximately four weeks after birth.  Of these, 
1413 replied and 854 consented to participate.  The majority of women who declined 
to participate reported they were too busy (n = 422). A further four women were 
excluded because their contact details could not be obtained.  A number of women 
who initially consented to participate did not complete any baseline measures; the 
final sample for analysis of baseline measures, including the PHQ-15, was 548. 
Women completed baseline measures by post or online. Participants also provided 
socio-demographic information. Obstetric information was obtained from medical 
records.  A detailed account of the design and procedure for the primary study can be 
found in the study protocol [REF removed for blind review]. 
Sample  
Table 1 summarizes mothers’ socio-demographic and obstetric characteristics. Most 
participants were white European, educated to degree level or higher, employed, and 
married/living with partner. Approximately 19% of women reported having been 
diagnosed with or treated for psychological problems at some point before their baby 
was born; 36 women (7.3%) reported having been diagnosed or treated since giving 
birth. Gestation was 37 weeks or more for 86% of the sample.  Approximately half 
were multiparous (52%), had normal vaginal births (55%), and experienced maternal 
and/or neonatal complications (53%).   
 
 Study measures 
Physical health questionnaire somatic symptom subscale (PHQ-15) 
The standard English version of the PHQ-15 [6] was used. Participants rated the 
severity of 15 symptoms experienced over the last four weeks as 0 (not bothered at 
all), 1 (bothered a little), or 2 (bothered a lot).  PHQ-15 scores can range from 0–30. 
Symptom severity was categorized as minimal (0–4), low (5–9), medium (10-14), or 
high (15 +) [6].  
Convergent validity measures 
As evidence of convergent validity of the PHQ-15, three outcomes were expected to 
vary based on symptom severity. These were women’s self-rated overall physical 
health, health-related quality of life (QoL), and primary care usage. In addition, 
women’s ratings of their baby’s health and primary care usage were explored.  
Convergent validity outcomes were operationally defined as follows:  
Overall physical health was rated by participants on a single item covering the most 
recent four weeks using a 10-point Likert scale (1 = extremely bad; 10 = best possible 
health). An identical single item was used to obtain the mother’s perception of their 
baby’s physical health. 
Health-related quality of life was measured using the SF-12v2 health survey, a 
reliable and valid 12-item self-report measure of QoL over the prior four weeks [18].  
Response options varied across items.  Women rated their overall general health with 
a 5-point Likert scale (1 = excellent; 5 = poor).  Five items were rated using Likert 
scales with lower values indicating poorer outcomes.  For example, the impact of 
bodily pain was measured by: ‘During the past four weeks, how much did pain 
interfere with your normal work including both outside the home and housework?’ (1 
= extremely; 5 = not at all).  Two items assessed the ability to conduct moderate 
 activities (e.g vacuuming, climbing stairs) using a 3-point scale (1 = yes, limited a lot; 
3 = No, not limited at all).   Four items had yes/no response options to further assess 
limitations due to physical health and emotional problems (During the past four 
weeks, did you accomplish less than you would like as a result of an emotional 
problem, such as feeling depressed or anxious?).   Quality Metric Incorporated 
calculated physical and mental component scores based on weighted, combined item 
scores using its proprietary SF-12v2 software.  Component scores range from 0 to 100 
with higher values indicating better QoL. The normative mean for both components is 
50 (SD =10). 
Primary care usage was measured as the number of visits for themselves to primary 
care or other healthcare professionals in a primary care setting for any reason with 
routine maternity care appointments excluded.  A similar item was used to measure 
primary care usage for their baby. 
Statistical analysis 
Full PHQ-15 data were obtained from 482 women; 66 women had missing data. Of 
these 66 participants, 13 had only a single missing value that varied across items. 
Median imputation was used for these values and the women were included in the 
final analysis (N = 495). The remaining 53 had missing data percentages considered 
inappropriate for statistical imputation (Widaman 2006).  Descriptive statistics were 
calculated for participants’ socio-demographic and obstetric characteristics, PHQ-15 
items, and convergent validity outcomes. PHQ-15 reliability was assessed using 
internal consistency statistics (Cronbach’s α, α if item deleted, corrected item-total 
correlations).  These statistics were chosen to facilitate comparison of the evidence 
from the current study with prior studies. One-way analyses of variance compared 
convergent validity outcomes by PHQ-15 symptom severity category with Bonferroni 
 adjustment implemented for post-hoc analyses. SPSS version 23.0 was used for all 
analyses. 
Results 
Evidence of reliability 
Internal consistency statistics are presented in Table 2. Cronbach’s α for the PHQ-15 
was 0.73; a value of 0.70 is considered satisfactory for group comparison (Streiner, 
2003).   Values for women reported in other studies ranged from 0.73 in a general 
sample of women (Hyphantis et al, 2014), 0.77 with young women (Nordin, 
Palmquist & Nordin, 2013), and 0.80 in the original obstetric-gynecology sample 
(Kroenke, Spitzer & Williams, 2002). Removing items did not improve Cronbach’s 
alpha. The average item-total correlation (0.33) and corrected item-total correlations 
(0.21 – 0.46) were within the recommended guidelines of a minimum of 0.15 – 0.20 
and 0.15 – 0.50 respectively (Streiner, 2003; Clark & Watson, 1995). 
Evidence of convergent validity 
Table 3 provides the correlations between the PHQ-15 and the outcomes for mother 
and baby.  Table 4 shows the differences in overall physical health, health-related 
QoL, and primary care usage for mother and baby by PHQ-15 symptom severity 
category. In this sample, 136 women (27%) were categorized as minimal, 247 (50%) 
as low, 83 (17%) as medium, and 29 (6%) as high in symptom severity. 
Mother’s perceived physical health, health-related quality of life and primary care 
usage 
Somatic symptom severity as measured by the PHQ-15 total score was significantly, 
negatively correlated with overall physical health rating and physical health-related 
QoL; and was significantly, positively associated with primary care usage by the 
 mother.  The relationship between somatic symptom severity and mental health-
related QoL was not significant (p = .16). 
Physical health ratings differed by PHQ-15 symptom severity category. 
Women categorized as minimal or low severity rated their own physical health higher 
than either medium or high severity groups (Welch’s F (3, 105.61) = 19.09, p < .001, 
η2p = .13). Physical health-related QoL also differed significantly by symptom 
severity category (Welch’s F (3, 105.04) = 31.93, p < .001, η2p = .17). Women 
categorized as either medium or high severity rated their physical health-related QoL 
lower than those with minimal or low symptoms. The mean rating by participants 
from the medium/high severity categories was approximately equal to the normed 
mean (50); those in the minimal/low severity category had mean ratings above the 
normed mean (+1.0 SD and +0.6 SD respectively).  Mental health-related QoL did not 
differ by symptom severity category (Welch’s F (3, 105.68) = 0.04, p = .99, η2p = 
.00).   
Primary care usage differed significantly by PHQ symptom severity category 
(Welch’s F (3, 102.01) = 6.79, p < .001, η2p = .04). Women with high severity 
reported more primary care visits for themselves than the minimal and low groups; 
visits by those in the medium severity category did not differ statistically from any 
other group. 
Mother’s ratings of baby’s physical health and primary care usage 
The entire sample rated their baby’s overall physical health highly; but a main effect 
of symptom severity category indicated women with high symptom severity rated 
their baby’s health lower than women in all other categories (Welch’s F (3, 105.90) = 
2.80, p < .05, η2p = .03).  Participants with high symptom severity also reported more 
 primary care usage for their baby than participants in all other categories (Welch’s F 
(3, 99.31) = 3.11, p < .05, η2p = .04). 
Discussion 
This study aimed to determine the reliability and convergent validity of the PHQ-15 
in postpartum women from a high-income country. The results provide evidence of 
the reliability and validity of the PHQ-15 for use with postpartum women. Internal 
consistency of the PHQ-15 was 0.73, a value consistent with those previously 
reported for women (Hyphantis et al, 2014; Nordin, Palmquist & Nordin, 2014). 
Corrected item-total correlations also indicated that all items exceeded established 
minimum criterion (Watson Clark, 1995).  Based on PHQ-15 scores, approximately 
6% of women were classified as having high symptom severity. This is a similar 
percentage to that reported in 18-34 year old women in Sweden (Nordin, Palmquist & 
Nordin, 2014) but less than the 9% reported in the obstetrics/gynaecology validity 
study (Kroenke, Spitzer & Williams, 2002) or 14% in a gynaecological cohort 
(Leithner et al, 2009), suggesting that using the PHQ-15 in a high-income postpartum 
sample does not over-identify women as high in symptom severity. Additional 
research should further explore the PHQ-15’s sensitivity and specificity with 
postpartum women. 
 There was evidence for good convergent validity of PHQ-15. Women with 
high levels of symptoms reported significantly worse overall physical health, poorer 
physical health-related QoL, and increased primary care usage. This is consistent with  
earlier studies indicating an association between the PHQ-15 and physical health-
related QoL and increased healthcare usage (Gierk et al,, 2009; Hyphantis et al, 2014; 
Kocalavent, Hinz &  Brahler, 2013; Kroenke Spitzer Williams 2002)   A new finding 
was that high symptom severity was also associated with overall physical health 
 ratings.  However, we found no difference in mental health-related QoL based on 
symptom severity, which is inconsistent with previous studies (Gierk et al,, 2009; 
Hyphantis et al, 2014; Kocalavent, Hinz &  Brahler, 2013). This may be because 
mental health-related QoL (as measured by the SF-12v2) includes questions on 
current energy level, time for social activity, and feelings of calmness/peacefulness, 
all of which are likely to be affected in any women caring for a new infant. 
Exploration of the impact of women’s physical symptoms on their perception 
of their baby’s health and primary care usage showed interesting results. Although 
women generally rated their baby’s health as good (with a mean of ~9 out of 10), 
women with severe symptoms rated their baby’s physical health as poorer than 
women in all other categories and reported more primary care visits for their baby. 
This may be due to anxiety about physical symptoms and/or health generally, which 
is transferred onto the baby. These types of anxiety also can be present in individuals 
with somatic symptom disorder (Dimsdale et al, 2013). It would therefore be 
interesting to see whether symptom severity on the PHQ-15 predicts the clinical 
diagnosis of somatic symptom disorder in a postpartum sample.  
It is documented that perinatal mental health problems impact both the mother 
and child (Bauer et al, 2014; Parfitt, Pike & Ayers, 2013; Stein et al, 2014). However, 
to date, perinatal mental health research has focused on depression and anxiety 
(Howard et al, 2014), with somatic disorders receiving less attention. One explanation 
for this may be due to the comorbidity of depression and/or anxiety with somatic 
symptom disorder or to the classification of these three conditions in the same group 
of common mental disorders (Faisal-Cury et al, 2010; Lowe et al, 2008; Shidaye et al, 
2013). While these disorders share similarities, there are also distinctions in 
presentation (Kroenke et al, 2010) and functional outcomes (Lowe et al, 2008). 
 Screening of physical symptom severity and possible somatic symptom disorder 
during the perinatal period may be important because women are more likely to be 
classified as high symptom severity than  (Hyphantis et al, 2014; Kroenke, Spitzer & 
Williams, 2002; Nordin, Palmquist & Nordin, 2013).  Similarly, mothers may report 
more child somatic symptoms than fathers (Gilleland, 2009), and parental 
somatization can lead to the development of somatization in children (Schulte & 
Peterman, 2011). The PHQ-15 potentially provides a useful measure of somatic 
symptoms in perinatal samples; and based on the current findings with postpartum 
women. 
The current study has a few limitations. The sample was comprised 
predominantly of white European women who were highly educated and therefore not 
representative of the general population of postpartum women. The self-reported rate 
of postpartum psychological problems in the current sample appears low at 7.3% 
compared to 15 - 20% usually reported (Gavin et al., 2005).  This may have been due 
to the wording for self-reports of psychological diagnosis or treatment pre and post-
birth.  Women were asked to indicate the presence of psychological problems ever 
prior to birth and, in a separate item, those since birth.  It may be women who 
reported pre-birth psychological problems did not then also indicate a problem since 
birth; therefore, it is difficult to ascertain the true post-partum rate in this sample.   
These study limitations may affect the generalizability of the current findings. Prior 
research has also indicated the PHQ-15 might perform differently across ethnic 
groups (Interian et al, 2006), so future research needs to examine the validity of the 
PHQ-15 in different ethnic groups.  Finally, the current study focused on postpartum 
women so similar research is needed to examine the validity of the PHQ-15 with 
pregnant women. 
 Conclusion 
Women often present with a range of physical symptoms during the perinatal 
period, making a brief, reliable and valid assessment tool to screen for somatic 
symptom severity useful in maternity care settings. The PHQ-15 has been widely used 
in other healthcare contexts and the current study supports the reliability and validity 
of the PHQ-15 for postpartum women. Women with severe symptoms reported poorer 
overall physical health of themselves and their baby, poorer physical health-related 
QoL, and greater use of primary care for themselves and their baby. The PHQ-15 
therefore has the potential to be a useful and valid measure of physical symptoms in 
postpartum women in high-income countries.  
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Current knowledge on the subject 
 Physical symptoms are common during pregnancy and after birth. 
 Measures of physical symptoms are needed that are reliable and valid for use 
with perinatal women. 
 The PHQ-15 is a measure of physical symptoms that has been widely used in 
other populations. 
 
What this study adds 
 This study determines the reliability and convergent validity of the PHQ-15 
for postpartum women in high-income countries. 
 Women with a high level of symptoms (6%) reported poorer physical health 
and greater use of primary care for themselves and their babies. 
 Women with a high level of symptoms also reported poorer physical health-
related quality of life.  
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 Table 1  Mothers' Socio-demographics and Obstetric Characteristics 
           
Mothers' Socio-demographics  Obstetric Characteristics   
  n  %    n  % 
           
Age [M (SD)]  32.77  ( 5.33) Labour duration in hours [M 
(SD)] 
5.53  ( 7.68) 
           
Ethnicity       Type of birth     
             
  White European  342  69.1    Normal vaginal birth 274  55.4 
             
  Other  20  4.0    Assisted*  181  36.6 
             
Education      Gestation      
             
  None  4  0.8    Less than 32 weeks 9  1.8 
             
  GCSE/O-level  45  9.1    32 - 36 weeks  22  4.4 
             
  A-level/Diploma  84  17.0    37 - 40 weeks  206  41.6 
             
  Degree  222  44.8    40 + weeks  219  44.2 
             
Employed      Parity     
             
  Yes  301  60.8    Primiparous  224  45.3 
             
  No  61  12.3    Multiparous  255  51.5 
             
Marital Status      Complications     
             
  Married  231  46.7    None  187  37.8 
             
  Living with partner 106  21.4    Maternal  131  26.5 
             
  Other  19  3.8    Neonatal  76  15.4 
             
Psychological Problems      Both  57  11.5 
(diagnosed/treated)          
             
  Prior to birth  95  19.2       
             
  Since giving birth 36  7.3       
           
           
Note:  Missing values ranged from 16 - 140 on these questions.  Therefore,  n and %  will not sum to 
the study N or 100%.         
           
* Ventouse, forceps or caesarian section births.     
 
 
 Table 2:  PHQ-15 Item and Item Total Statistics (N = 495)   
           
Item  M  SD  Cronbach's alpha Cronbach's alpha 
if item deleted 
Corrected rIT 
           
Total PHQ score  7.02  3.99  0.73    0.33 
           
Stomach pain  0.46  0.60    0.71  0.34 
           
Back pain  0.96  0.74    0.72  0.30 
           
Pain in your arms, legs, or joints 0.56  0.68    0.72  0.30 
           
Menstrual problems  0.31  0.57    0.70  0.41 
           
Pain or problems during intercourse 0.37  0.62    0.73  0.21 
           
Headaches  0.58  0.65    0.71  0.34 
           
Chest pain  0.06  0.28    0.72  0.27 
           
Dizziness  0.39  0.58    0.71  0.38 
           
Fainting spells  0.06  0.29    0.72  0.26 
           
Feeling your heart pound or race 0.15  0.40    0.71  0.39 
           
Shortness of breath  0.16  0.42    0.71  0.41 
           
Diarrhea/constipation  0.68  0.73    0.72  0.28 
           
Nausea/gas/indigestion  0.43  0.63    0.70  0.46 
           
Feeling tired or having low energy 1.29  0.62    0.70  0.40 
           
Trouble sleeping  0.57  0.70    0.71  0.35 
           
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Table 4:  Differences in Mothers' Physical and Mental Health Related Quality of Life, Overall Physical Health Ratings for Mother and Baby, and Primary Care Visits for
Mother and Baby by PHQ-15 Symptom Severity Category
Outcome M SD M SD M SD M SD M SD F η
2
p Post-hoc
SF12 v2 Health related quality of life
  Physical health 55.99 8.82 60.69 6.10 55.80 7.96 51.71 9.62 47.88 11.59 31.93 *** 0.17 Mi > L > Me = H
  Mental health 41.32 5.85 41.33 4.54 41.38 5.83 41.27 7.04 40.86 7.82 0.04 NS 0.00
Overall physical health rating
  Mother 7.81 1.43 8.38 1.14 7.86 1.31 7.21 1.43 6.48 2.01 19.09 *** 0.13 Mi > L > Me = H
  Baby 9.09 1.16 9.29 1.04 9.07 1.11 9.07 1.12 8.41 1.84 2.80 * 0.03 Mi = L = Me > H
Primary care visits (non-routine)
  Mother 0.86 1.26 0.54 0.94 0.87 1.22 1.10 1.58 1.54 1.45 6.79 *** 0.04 Mi & Low < H
Mi = L = Me
  Baby 0.92 1.32 0.71 1.15 0.88 1.22 1.01 1.31 1.89 2.18 3.11 * 0.04 Mi = L = Me > H
Note:  N varied across analyses due to missing data on outcomes.  Maximum n for each symptom severity category is provided.  * p  < .05, *** p  < .001.  
n = 136 n = 247 n = 83 n = 29
PHQ-15 symptom severity category
Overall
Minimal Low Medium High
